Jefferies Group LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 195 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$3,979,138
+1144.9%
376,100
+1096.6%
0.03%
+1033.3%
Q1 2021$319,643
+741.2%
31,430
+66.9%
0.00%
Q1 2020$38,000
-96.5%
18,829
-94.0%
0.00%
-100.0%
Q4 2019$1,087,000
+274.8%
315,000
+587.8%
0.01%
+300.0%
Q4 2016$290,000
+62.9%
45,800
+13.1%
0.00%
+100.0%
Q3 2016$178,00040,5000.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
DG Capital Management, LLC 1,186,726$4,076,0002.45%
Sarissa Capital Management LP 4,861,000$16,697,0001.97%
Ghost Tree Capital, LLC 1,950,000$6,698,0001.94%
ORACLE INVESTMENT MANAGEMENT INC 2,525,857$8,676,0001.14%
Eversept Partners, LP 1,143,211$3,926,9300.87%
DAFNA Capital Management LLC 749,051$2,573,0000.84%
KNOTT DAVID M 397,361$1,365,0000.80%
Parkman Healthcare Partners LLC 800,740$2,751,0000.73%
ACUTA CAPITAL PARTNERS, LLC 660,000$2,267,0000.62%
Formidable Asset Management, LLC 578,200$1,949,0000.57%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders